ImmuCell Operating Margin 2010-2025 | ICCC
Current and historical operating margin for ImmuCell (ICCC) over the last 10 years. The current operating profit margin for ImmuCell as of March 31, 2025 is -1.00%.
| ImmuCell Operating Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Operating Income | Operating Margin |
| 2025-03-31 | $0.03B | 0 | 0.00% |
| 2024-12-31 | $0.03B | $0.00B | -3.85% |
| 2024-09-30 | $0.02B | $0.00B | -13.04% |
| 2024-06-30 | $0.02B | $0.00B | -13.64% |
| 2024-03-31 | $0.02B | $0.00B | -14.29% |
| 2023-12-31 | $0.02B | $-0.01B | -29.41% |
| 2023-09-30 | $0.02B | $-0.01B | -37.50% |
| 2023-06-30 | $0.02B | $-0.01B | -37.50% |
| 2023-03-31 | $0.02B | $-0.01B | -37.50% |
| 2022-12-31 | $0.02B | $0.00B | -15.79% |
| 2022-09-30 | $0.02B | $0.00B | -5.00% |
| 2022-06-30 | $0.02B | 0 | 0.00% |
| 2022-03-31 | $0.02B | $0.00B | 4.76% |
| 2021-12-31 | $0.02B | 0 | 0.00% |
| 2021-09-30 | $0.02B | $0.00B | -5.56% |
| 2021-06-30 | $0.02B | $0.00B | -5.88% |
| 2021-03-31 | $0.02B | $0.00B | -13.33% |
| 2020-12-31 | $0.02B | $0.00B | -12.50% |
| 2020-09-30 | $0.02B | $0.00B | -6.25% |
| 2020-06-30 | $0.02B | $0.00B | -6.67% |
| 2020-03-31 | $0.02B | $0.00B | -6.67% |
| 2019-12-31 | $0.01B | $0.00B | -7.14% |
| 2019-09-30 | $0.01B | $0.00B | -15.38% |
| 2019-06-30 | $0.01B | $0.00B | -16.67% |
| 2019-03-31 | $0.01B | $0.00B | -8.33% |
| 2018-12-31 | $0.01B | $0.00B | -9.09% |
| 2018-09-30 | $0.01B | 0 | 0.00% |
| 2018-06-30 | $0.01B | 0 | 0.00% |
| 2018-03-31 | $0.01B | 0 | 0.00% |
| 2017-12-31 | $0.01B | $0.00B | 9.09% |
| 2017-09-30 | $0.01B | $0.00B | 10.00% |
| 2017-06-30 | $0.01B | $0.00B | 10.00% |
| 2017-03-31 | $0.01B | $0.00B | 10.00% |
| 2016-12-31 | $0.01B | $0.00B | 11.11% |
| 2016-09-30 | $0.01B | $0.00B | 10.00% |
| 2016-06-30 | $0.01B | $0.00B | 20.00% |
| 2016-03-31 | $0.01B | $0.00B | 20.00% |
| 2015-12-31 | $0.01B | $0.00B | 20.00% |
| 2015-09-30 | $0.01B | $0.00B | 22.22% |
| 2015-06-30 | $0.01B | $0.00B | 11.11% |
| 2015-03-31 | $0.01B | $0.00B | 11.11% |
| 2014-12-31 | $0.01B | 0 | 0.00% |
| 2014-09-30 | $0.01B | 0 | 0.00% |
| 2014-06-30 | $0.01B | 0 | 0.00% |
| 2014-03-31 | $0.01B | 0 | 0.00% |
| 2013-12-31 | $0.01B | 0 | 0.00% |
| 2013-09-30 | $0.01B | 0 | 0.00% |
| 2013-06-30 | $0.01B | 0 | 0.00% |
| 2013-03-31 | $0.01B | 0 | 0.00% |
| 2012-12-31 | $0.01B | 0 | 0.00% |
| 2012-09-30 | $0.01B | 0 | 0.00% |
| 2012-06-30 | $0.01B | 0 | 0.00% |
| 2012-03-31 | $0.01B | 0 | 0.00% |
| 2011-12-31 | $0.01B | 0 | 0.00% |
| 2011-09-30 | $0.01B | $0.00B | -40.00% |
| 2011-06-30 | $0.01B | $0.00B | -40.00% |
| 2011-03-31 | $0.01B | $0.00B | -40.00% |
| 2010-12-31 | $0.00B | $0.00B | -50.00% |
| 2010-09-30 | $0.00B | 0 | 0.00% |
| 2010-06-30 | $0.00B | 0 | 0.00% |
| 2010-03-31 | $0.00B | 0 | 0.00% |
| 2009-12-31 | $0.00B | 0 | 0.00% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $0.055B | $0.026B |
| ImmuCell Corp. is a biotechnology company striving to build shareholder value by commercializing proprietary technologies and helping dairy and beef producers and their veterinarians manage disease and reproduction in their herds. The company is also conducting an open label, efficacy study of DiffGAM, a human application of its milk-derived passive antibodytechnology for use as an alternative to antibiotics in the treatment and/or prevention of Clostridium difficile-associated diarrhea. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $229.845B | 26.95 |
| Boston Scientific (BSX) | United States | $152.561B | 36.38 |
| Stryker (SYK) | United States | $143.889B | 29.29 |
| EssilorLuxottica (ESLOY) | France | $136.285B | 0.00 |
| Medtronic (MDT) | Ireland | $116.952B | 16.59 |
| Lonza Group Ag (LZAGY) | Switzerland | $48.016B | 0.00 |
| Haleon (HLN) | United Kingdom | $42.497B | 24.26 |
| ResMed (RMD) | United States | $41.081B | 29.34 |
| GE HealthCare Technologies (GEHC) | United States | $32.462B | 15.26 |
| Agilent Technologies (A) | United States | $32.378B | 21.11 |
| Terumo (TRUMY) | Japan | $27.642B | 32.75 |
| Koninklijke Philips (PHG) | Netherlands | $25.623B | 16.95 |
| Insulet (PODD) | United States | $21.362B | 71.59 |
| Zimmer Biomet Holdings (ZBH) | United States | $19.474B | 12.41 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $15.802B | 0.00 |
| Baxter (BAX) | United States | $12.091B | 9.34 |
| Sunny Optical Technology (SNPTF) | China | $10.417B | 0.00 |
| Demant (WILYY) | Denmark | $8.599B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $7.179B | 26.37 |
| Lantheus Holdings (LNTH) | United States | $3.730B | 10.09 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| Prestige Consumer Healthcare (PBH) | United States | $3.341B | 14.76 |
| Envista Holdings (NVST) | United States | $3.339B | 23.36 |
| ICU Medical (ICUI) | United States | $3.197B | 21.83 |
| Perrigo (PRGO) | Ireland | $3.141B | 7.85 |
| Haemonetics (HAE) | United States | $2.673B | 11.96 |
| LeMaitre Vascular (LMAT) | United States | $2.134B | 45.76 |
| AtriCure (ATRC) | United States | $1.784B | 0.00 |
| QuidelOrtho (QDEL) | United States | $1.657B | 10.43 |
| Green Thumb Industries (GTBIF) | United States | $1.478B | 63.46 |
| AdaptHealth (AHCO) | United States | $1.252B | 17.85 |
| Curaleaf Holdings (CURLF) | Canada | $1.200B | 0.00 |
| Acuren (TIC) | United States | $1.180B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $1.108B | 14.16 |
| Neogen (NEOG) | United States | $1.086B | 17.24 |
| BioLife Solutions (BLFS) | United States | $0.987B | 2064.00 |
| InMode (INMD) | Israel | $0.908B | 8.40 |
| Kestra Medical Technologies (KMTS) | United States | $0.757B | 0.00 |
| Valneva SE (VALN) | France | $0.702B | 0.00 |
| Tilray Brands (TLRY) | Canada | $0.655B | 0.00 |
| ZimVie (ZIMV) | United States | $0.532B | 20.49 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.516B | 0.00 |
| Surmodics (SRDX) | United States | $0.501B | 0.00 |
| Owens & Minor (OMI) | United States | $0.487B | 4.04 |
| CeriBell (CBLL) | United States | $0.461B | 0.00 |
| SNDL (SNDL) | Canada | $0.439B | 0.00 |
| Evolus (EOLS) | United States | $0.393B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.369B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.334B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.322B | 11.16 |
| Verano Holdings (VRNOF) | United States | $0.307B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.304B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.294B | 0.00 |
| Quanterix (QTRX) | United States | $0.275B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.270B | 20.47 |
| Cerus (CERS) | United States | $0.238B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.237B | 0.00 |
| Omeros (OMER) | United States | $0.233B | 0.00 |
| Brainsway (BWAY) | Israel | $0.224B | 59.15 |
| Sanara MedTech (SMTI) | United States | $0.217B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.215B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.201B | 0.00 |
| Vireo Growth (VREOF) | United States | $0.200B | 0.00 |
| Exagen (XGN) | United States | $0.198B | 0.00 |
| Organigram Global (OGI) | Canada | $0.189B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.181B | 14.89 |
| High Tide (HITI) | Canada | $0.177B | 0.00 |
| Biote (BTMD) | United States | $0.160B | 4.79 |
| TerrAscend (TSNDF) | Canada | $0.156B | 0.00 |
| Safety Shot (SHOT) | United States | $0.139B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.139B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.137B | 16.81 |
| Jushi Holdings (JUSHF) | United States | $0.124B | 0.00 |
| MacroGenics (MGNX) | United States | $0.102B | 0.00 |
| Jin Medical (ZJYL) | China | $0.100B | 0.00 |
| Fonar (FONR) | United States | $0.098B | 12.63 |
| Quipt Home Medical (QIPT) | United States | $0.093B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.085B | 0.00 |
| Apyx Medical (APYX) | United States | $0.074B | 0.00 |
| Agape ATP (ATPC) | $0.067B | 0.00 | |
| Cytosorbents (CTSO) | United States | $0.056B | 0.00 |
| Veru (VERU) | United States | $0.055B | 0.00 |
| Zynex (ZYXI) | United States | $0.045B | 0.00 |
| Modular Medical (MODD) | United States | $0.040B | 0.00 |
| United-Guardian (UG) | United States | $0.036B | 12.60 |
| Rockwell Medical (RMTI) | United States | $0.033B | 0.00 |
| Nephros (NEPH) | United States | $0.031B | 24.08 |
| Allurion Technologies (ALUR) | United States | $0.021B | 0.00 |
| INLIF (INLF) | $0.017B | 0.00 | |
| Trinity Biotech (TRIB) | Ireland | $0.016B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.013B | 0.00 |
| Senestech (SNES) | United States | $0.012B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.010B | 0.00 |
| Flora Growth (FLGC) | United States | $0.010B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.009B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.009B | 0.00 |
| Sharps Technology (STSS) | United States | $0.005B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.003B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| InterCure (INCR) | Israel | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |